Would you ever consider stopping immunotherapy in a patient with metastatic melanoma after achieving a good response?
2
1 Answers
Mednet Member
Medical Oncology · University of Texas MD Anderson Cancer Center
Yes, I would consider stopping immunotherapy in a patient with metastatic melanoma after achieving a good response.
Data of 655 melanoma patients treated in pembrolizumab phase 1 KEYNOTE-001 study has shown 95 patients (14.5%) achieved CR after a median follow-up of 32 months. Treatment was discontin...